Infusion Therapies in the Treatment of Parkinson's Disease

Teus van Laar, K Ray Chaudhuri, Angelo Antonini, Tove Henriksen, Maja Trošt

Abstract

Oral levodopa is the gold-standard therapy for treating Parkinson's disease (PD) but after a few years of treatment the therapeutic window narrows, and patients often experience various treatment-related complications. Patients in this advanced PD stage may benefit from alternative therapy, such as continuous intrajejunal delivery of levodopa-carbidopa intestinal gel (LCIG; or carbidopa-levodopa enteral suspension), continuous intrajejunal delivery of levodopa-carbidopa-entacapone intestinal gel, or continuous subcutaneous apomorphine infusion. Consideration and initiation of infusion therapies in advanced PD are suggested before the onset of major disability. The present review summarizes clinical evidence for infusion therapy in advanced PD management, discusses available screening tools for advanced PD, and provides considerations around optimal use of infusion therapy.

OriginalsprogEngelsk
TidsskriftJournal of Parkinson's Disease
Vol/bind13
Udgave nummer5
Sider (fra-til)641-657
Antal sider17
ISSN1877-7171
DOI
StatusUdgivet - 2023

Fingeraftryk

Dyk ned i forskningsemnerne om 'Infusion Therapies in the Treatment of Parkinson's Disease'. Sammen danner de et unikt fingeraftryk.

Citationsformater